This federal contract award is for pharmaceutical products and medical supplies to be provided by AmerisourceBergen Drug Corp to the Defense Logistics Agency (DLA). The contract, valued at $4,142.90, is a delivery order with a firm fixed price pricing type and an ultimate completion date of December 5, 2024.
The contract covers a variety of medical commodities, including the specific product "ISENTRESS 400 MG TABLET 60S." It is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract award does not have a set-aside designation, indicating it was open to competition. AmerisourceBergen, as the prime contractor, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.
Generated 3/5/25, 10:16 AM